A multicenter, randomized, open-label, parallel-group study of EN-P11 in patients with enteral tube feeding.

Authors
Category Primary study
Registry of TrialsJapan Primary Registry Network
Year 2023
INTERVENTION: Either EN‐P11 or control drug is given to patients through enteral tube to perform nutritional management for eleven consecutive days. CONDITION: Patients with enteral tube feeding. PRIMARY OUTCOME: transthyretin, retinol‐binding protein, transferrin INCLUSION CRITERIA: 1. Receiving enteral feeding via enteral tube. 2. Patients being hospitalized. 3. Aged 18 years or older at the time of obtaining informed consent. 4.Written informed consent of free will has been obtained.
Epistemonikos ID: b0206652580dda11afbc39048ff9ed9b962d304a
First added on: Aug 26, 2024